Amphastar Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Amphastar Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2024.
  • Amphastar Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $32.1M, a 21.9% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $32.1M +$5.78M +21.9% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $31.4M +$5.55M +21.5% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $32.3M +$6.78M +26.5% Dec 31, 2023 10-Q 2024-08-09
Q3 2023 $32.7M +$6.21M +23.5% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $26.3M -$635K -2.36% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $25.8M -$2.04M -7.33% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $25.6M -$1.34M -4.98% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $26.5M -$1.21M -4.36% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $27M -$207K -0.76% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $27.8M +$8.56M +44.4% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $26.9M +$6.85M +34.2% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $27.7M +$7.41M +36.6% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $27.2M +$10.1M +59% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $19.3M +$1.35M +7.51% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $20M +$1.24M +6.58% Dec 31, 2020 10-K 2022-03-11
Q3 2020 $20.3M +$793K +4.07% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $17.1M -$3.06M -15.2% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $17.9M +$4.45M +33% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $18.8M Dec 31, 2019 10-K 2021-03-15
Q3 2019 $19.5M Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $20.1M Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $13.5M Mar 31, 2019 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.